Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.
2.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
3.

Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

Carter NJ, McCormack PL.

CNS Drugs. 2009;23(6):523-41. doi: 10.2165/00023210-200923060-00006. Review.

PMID:
19480470
4.

Dose-response relationship with venlafaxine.

Kelsey JE.

J Clin Psychopharmacol. 1996 Jun;16(3 Suppl 2):21S-26S; discussion 26S-28S. Review.

PMID:
8784645
5.

[Neurobiology and pharmacotherapy of social phobia].

Aouizerate B, Martin-Guehl C, Tignol J.

Encephale. 2004 Jul-Aug;30(4):301-13. Review. French.

PMID:
15538306
6.

Extended-release formulation of venlafaxine in the treatment of post-traumatic stress disorder.

Pae CU, Lim HK, Ajwani N, Lee C, Patkar AA.

Expert Rev Neurother. 2007 Jun;7(6):603-15. Review.

PMID:
17563244
7.

A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder.

Allgulander C, Nutt D, Detke M, Erickson J, Spann M, Walker D, Ball S, Russell J.

J Psychopharmacol. 2008 Jun;22(4):417-25. doi: 10.1177/0269881108091588.

PMID:
18635722
8.

Clinical evaluation of venlafaxine.

Ballenger JC.

J Clin Psychopharmacol. 1996 Jun;16(3 Suppl 2):29S-35S; discussion 35S-36S. Review.

PMID:
8784646
9.
10.

Defining response and remission in anxiety disorders: toward an integrated approach.

Bandelow B.

CNS Spectr. 2006 Oct;11(10 Suppl 12):21-8. Review.

PMID:
17008827
11.

The treatment of childhood social anxiety disorder.

Beidel DC, Ferrell C, Alfano CA, Yeganeh R.

Psychiatr Clin North Am. 2001 Dec;24(4):831-46. Review.

PMID:
11723636
12.

A review of 19 double-blind placebo-controlled studies in social anxiety disorder (social phobia).

Versiani M.

World J Biol Psychiatry. 2000 Jan;1(1):27-33. Review.

PMID:
12607230
13.

Venlafaxine extended release (XR) in the treatment of generalized anxiety disorder.

Sheehan DV.

J Clin Psychiatry. 1999;60 Suppl 22:23-8. Review.

14.

Long-term treatment strategies in anxiety disorders.

Allgulander C, Hirschfeld RM, Nutt DJ.

Psychopharmacol Bull. 2002 Summer;36 Suppl 2:79-92. Review.

PMID:
12490824
15.

Venlafaxine: a 2003 update.

Gutierrez MA, Stimmel GL, Aiso JY.

Clin Ther. 2003 Aug;25(8):2138-54. Review.

PMID:
14512125
16.

Use of venlafaxine in other psychiatric disorders.

Ninan PT.

Depress Anxiety. 2000;12 Suppl 1:90-4. Review.

PMID:
11098421
17.

The safety of SSRIs in generalised anxiety disorder: any reason to be anxious?

Masand PS, Gupta S.

Expert Opin Drug Saf. 2003 Sep;2(5):485-93. Review.

PMID:
12946249
18.

Fluvoxamine: a review of its therapeutic potential in the management of anxiety disorders in children and adolescents.

Cheer SM, Figgitt DP.

Paediatr Drugs. 2001;3(10):763-81. Review. Erratum in: Paediatr Drugs 2001;3(11):801.

PMID:
11706925
19.

[Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].

Ammar G, Naja WJ, Pelissolo A.

Encephale. 2015 Jun;41(3):260-5. doi: 10.1016/j.encep.2013.11.002. Epub 2014 Nov 14. Review. French.

PMID:
25439852
20.

The role of drug therapy in social phobia.

Lydiard RB.

J Affect Disord. 1998 Sep;50 Suppl 1:S35-9. Review.

PMID:
9851577

Supplemental Content

Support Center